Hemogenyx (HEMO.L): in vivo data for CDX antibody as conditioning therapy | Amphion Innovations (AMP.L): Loan facility update
12 Jun 2019
SPA Healthcare - Morning Comment
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SPA Healthcare - Morning Comment
- Published:
12 Jun 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Hemogenyx (HEMO.L): in vivo data for CDX antibody as conditioning therapy | Amphion Innovations (AMP.L): Loan facility update